Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Microbot Medical Inc’s stock clocked out at $2.61, up 7.41% from its previous closing price of $2.43. In other words, the price has increased by $7.41 from its previous closing price. On the day, 4.99 million shares were traded.
Ratios:
To gain a deeper understanding of MBOT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.37 and its Current Ratio is at 2.37. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 13, 2020, Reiterated its Buy rating but revised its target price to $26 from $12 previously.
On December 24, 2019, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $10 to $12.
On January 31, 2018, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $1.75.Ladenburg Thalmann initiated its Buy rating on January 31, 2018, with a $1.75 target price.
Stock Price History:
Over the past 52 weeks, MBOT has reached a high of $3.38, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 50.83%, while the 200-Day Moving Average is calculated to be 100.17%.
Shares Statistics:
A total of 34.74M shares are outstanding, with a floating share count of 31.69M. Insiders hold about 8.78% of the company’s shares, while institutions hold 6.91% stake in the company.
